EQT’s Sale of an Additional 10% in Galderma to L’Oréal, Reinforcing L’Oréal’s Strategic Investment in Galderma

•

By

CapLaw

Share on:

On 8 December 2025, EQT announced the sale of an additional 10% stake in Galderma Group AG (SIX: GALD) by a consortium led by EQT, which includes Sunshine SwissCo GmbH (SSCO), Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as sellers) to L’Oréal S.A. for an undisclosed amount. Following the transaction, which is subject to customary regulatory approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The previously concluded shareholder undertaking between SSCO and L’Oréal will be dissolved effective upon completion of the transaction.

Back to the homepage
CapLaw Themes
CapLaw PDF Archive

Discover more articles

We provide up-to-date information on legal and regulatory developments regarding the capital markets, publish concise articles on developments in the Swiss and international financial markets, and announce recent deals and forthcoming events.

  • Note from the Editors | Strengthening the “Too Big to Fail” Regime in Switzerland

    By

    CapLaw

    The collapse of Credit Suisse in March 2023 has served as a powerful catalyst for a renewed and intensified debate on the effectiveness of Switzerland’s ‘too big to fail’ (TBTF) regulatory framework. In response, the Swiss Federal Council has presented a comprehensive package of measures aimed at strengthening banking stability and mitigating the risks posed…

    Read more: Note from the Editors | Strengthening the “Too Big to Fail” Regime in Switzerland

  • EARLY INTERVENTION REGIME

    By

    Nina Reiser

    On 6 June 2025, the Swiss Federal Council published proposed additional powers for the Swiss Financial Market Supervisory Authority FINMA. This article assesses the intended early intervention regime.

    Read more: EARLY INTERVENTION REGIME

  • A “Swiss Senior Managers Regime”: Less Is More

    By

    Nicolas Curchod

    /

    Dusan Ivanovic

    The Federal Council welcomes the introduction of a supervisory regime for senior managers of Swiss banks, citing perceived gaps in regulatory accountability. In fact, what is needed is not a new regulatory regime modelled on the British “senior managers regime”, but rather clarification and refinement of the current framework.

    Read more: A “Swiss Senior Managers Regime”: Less Is More

  • The Proposal to Grant FINMA the Power to Impose Fines

    By

    Claudio Bazzani

    /

    Reto Ferrari-Visca

    This article examines the proposal to grant Swiss Financial Market Supervisory Authority (FINMA) the power to impose fines. The initiative, once seen as unlikely, gained renewed attention after the collapse of Credit Suisse and has since been supported by FINMA and considered by the Federal Council and the Swiss Parliament. While proponents emphasise deterrence, international…

    Read more: The Proposal to Grant FINMA the Power to Impose Fines

  • Idorsia Ltd’s Placement of 16.4 Million Shares through Accelerated Bookbuilding

    By

    CapLaw

    On 10 October 2025, Idorsia Ltd (SIX-listed) announced the launch of an accelerated bookbuilding offering, which led to the placement of 16.4 million shares at an offer price of CHF 4.00 per offered share, raising aggregate gross proceeds of approximately CHF 65.6 million. J.P. Morgan and UBS acted as Joint Bookrunners and Global Coordinators, and…

    Read more: Idorsia Ltd’s Placement of 16.4 Million Shares through Accelerated Bookbuilding

  • DocMorris Finance B.V.’s Placement of CHF 49.6 Million Convertible Bonds Due 2028 and Early Buyback of Convertible Bonds due 2026

    By

    CapLaw

    On 22 October 2025, DocMorris Finance B.V., a subsidiary of DocMorris AG (SIX: DOCM), placed EUR 49.6 million senior unsecured bonds due 2028 and convertible into shares of DocMorris AG. Further, in November 2025, DocMorris Finance B.V. conducted a tender offer for its outstanding convertible bonds due 2026 at 103.5% of the par value plus…

    Read more: DocMorris Finance B.V.’s Placement of CHF 49.6 Million Convertible Bonds Due 2028 and Early Buyback of Convertible Bonds due 2026